Demo and applications technology center opens on September 1
Global demand for labels in pharmaceutical applications is projected to increase 7.1 percent annually, reaching 5.1 billion sqm in 2020, according to a new report.
The 8th edition of Freedonia Group’s Global Labels Market report identifies this trajectory as the fastest growth rate among major label markets. Trends favoring the use of smaller-sized medication containers will increase the number of labels required by pharmaceutical manufacturers, as will overall increases in drug production, while growth will also benefit from intensified efforts to combat drug counterfeiting and diversion. This trend will shift consumption toward higher value-added products with enhanced security features such as RFID tags, serialization codes, holograms, color shifting inks and other anti-piracy measures.
The largest share of demand for pharmaceutical labels exists in adhesive-sealed and pressure-sensitive paper configurations that are sold in rollstocks. Clear plastic and silk-screened configurations are gaining market share due to their high visibility and tamper-evident features.
‘These value-added labels are finding increased use in the over-the-counter (OTC) drug segment, where greater competition is boosting demand for labels that enhance the perceived value of products,’ explained Freedonia Group analyst Mike Richardson.
Most of the global market for pharmaceutical labels is divided between security and standard types, states the report. Security labels, which include authentication markings and/or track and trace features to inhibit drug counterfeiting and diversion, will continue to post faster growth. However, standard labels will sustain widespread usage in the packaging of generic ethical drugs and non-proprietary OTC products. These pharmaceuticals are less vulnerable to counterfeiting and diversion due to their lower prices. Standard labels will also continue to dominate applications involving prescription drugs dispensed by retail and mail order pharmacies.